Enzon Pharmaceuticals, Inc. (ENZN)

Enzon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	13	7	18	25	13	9
Market Cap Growth	-69.90%	-62.07%	-27.99%	100.25%	39.36%	-18.25%
Enterprise Value	-33	-40	-29	-22	-35	4
PE Ratio	56.67	5.06	-98.41	-54.20	-9.68	-9.30
PS Ratio	-	-	704.04	36.26	244.10	44.00
PB Ratio	0.27	0.15	0.40	0.54	0.27	1.50
P/FCF Ratio	9.10	5.32	-27.78	-50.74	-33.40	1.32
P/OCF Ratio	9.10	5.32	-27.78	-50.74	-33.40	1.32
EV/Sales Ratio	-	-	-1102.96	-31.70	-681.71	17.69
EV/EBITDA Ratio	37.03	38.38	27.79	47.38	27.16	-3.76
EV/FCF Ratio	-28.99	-30.70	43.52	44.36	93.29	0.53
Quick Ratio	88.27	27.43	27.65	118.29	116.92	14.02
Current Ratio	89.19	27.62	27.89	118.50	117.07	14.17
Asset Turnover	0	0	0.00	0.01	0.00	0.03
Interest Coverage	0	0	1.60	0	0	0
Return on Equity (ROE)	3.23%	2.99%	-0.41%	-0.99%	-2.74%	-16.17%
Return on Assets (ROA)	3.19%	2.88%	-0.39%	-0.98%	-2.72%	-15.11%
Return on Capital (ROIC)	-2.55%	-2.56%	-2.25%	-0.99%	-2.73%	-16.07%
Earnings Yield	11.86%	19.78%	-1.02%	-1.85%	-10.33%	-10.75%
FCF Yield	10.99%	18.80%	-3.60%	-1.97%	-2.99%	75.81%
Dividend Yield	21.96%	18.36%	0.00%	0.00%	0.00%	87.38%
Payout Ratio	398.44%	92.86%	0.00%	0.00%	0.00%	-812.97%
Buyback Yield / Dilution	-	-	-45.23%	-15.57%	-
Total Shareholder Return	21.96%	18.36%	-	-45.23%	-15.57%	87.38%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.